BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35452300)

  • 1. Photobiomodulation Modulates Interleukin-10 and Interferon Gamma Production by Mononuclear Cells from Healthy Donors and Persons with Multiple Sclerosis.
    Tolentino M; Cho CC; Lyons JA
    Photobiomodul Photomed Laser Surg; 2022 Apr; 40(4):234-244. PubMed ID: 35452300
    [No Abstract]   [Full Text] [Related]  

  • 2. Photobiomodulation at 830 nm Reduced Nitrite Production by Peripheral Blood Mononuclear Cells Isolated from Multiple Sclerosis Subjects.
    Tolentino M; Cho CC; Lyons JA
    Photobiomodul Photomed Laser Surg; 2022 Jul; 40(7):480-487. PubMed ID: 35793511
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells in multiple sclerosis patients.
    Selmaj K; Nowak Z; Tchórzewski H
    J Neurol Sci; 1988 May; 85(1):67-76. PubMed ID: 3260270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis.
    Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):411-6. PubMed ID: 8807205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment.
    Ozenci V; Kouwenhoven M; Huang YM; Xiao B; Kivisäkk P; Fredrikson S; Link H
    Scand J Immunol; 1999 May; 49(5):554-61. PubMed ID: 10320650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of retinyl-palmitate on the level of pro and anti-inflammatory cytokines in multiple sclerosis patients: A randomized double blind clinical trial.
    Bitarafan S; Mohammadpour Z; Jafarirad S; Harirchian MH; Yekaninejad MS; Saboor-Yaraghi AA
    Clin Neurol Neurosurg; 2019 Feb; 177():101-105. PubMed ID: 30640138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients.
    Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
    Clin Diagn Lab Immunol; 1995 Nov; 2(6):766-9. PubMed ID: 8574845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estrogen on Th1, Th2 and Th17 cytokines production by proteolipid protein and PHA activated peripheral blood mononuclear cells isolated from multiple sclerosis patients.
    Javadian A; Salehi E; Bidad K; Sahraian MA; Izad M
    Arch Med Res; 2014 Feb; 45(2):177-82. PubMed ID: 24486244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients.
    Porrini AM; Gambi D; Reder AT
    J Neuroimmunol; 1995 Aug; 61(1):27-34. PubMed ID: 7560009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.
    Melnikov M; Sharanova S; Sviridova A; Rogovskii V; Murugina N; Nikolaeva A; Dagil Y; Murugin V; Ospelnikova T; Boyko A; Pashenkov M
    PLoS One; 2020; 15(10):e0240305. PubMed ID: 33126239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
    Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis.
    Wang X; Chen M; Wandinger KP; Williams G; Dhib-Jalbut S
    J Immunol; 2000 Jul; 165(1):548-57. PubMed ID: 10861095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased in vitro induced CD4+ and CD8+ T cell IFN-gamma and CD4+ T cell IL-10 production in stable relapsing multiple sclerosis.
    Brod SA; Nelson LD; Khan M; Wolinsky JS
    Int J Neurosci; 1997 Aug; 90(3-4):187-202. PubMed ID: 9352427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
    Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production.
    Chung SW; Yoshida EM; Cattral MS; Hu Y; Gorczynski RM
    Immunol Lett; 1998 Sep; 63(2):91-6. PubMed ID: 9761370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission.
    Hollifield RD; Harbige LS; Pham-Dinh D; Sharief MK
    Autoimmunity; 2003 May; 36(3):133-41. PubMed ID: 12911279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
    Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
    Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis.
    Link J; He B; Navikas V; Palasik W; Fredrikson S; Söderström M; Link H
    J Neuroimmunol; 1995 Apr; 58(1):21-35. PubMed ID: 7537278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10.
    Huang YM; Stoyanova N; Jin YP; Teleshova N; Hussien Y; Xiao BG; Fredrikson S; Link H
    Clin Exp Immunol; 2001 May; 124(2):306-14. PubMed ID: 11422209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.